Investor Alert

Intra-Cellular Therapies Inc.



After Hours

 --Quotes are delayed by 20 min

Sep 30, 2022, 6:00 p.m.





+0.27 +0.58%


Volume 129,612

Quotes are delayed by 20 min


Previous close

$ 45.25

$ 46.53


+1.28 +2.83%

Day low

Day high




52 week low

52 week high




Annual Financials for Intra-Cellular Therapies Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (97.77M)(155.13M)(147.72M)(227.01M)(284.13M)
Depreciation, Depletion & Amortization 213,872368,673477,121528,118533,360
Depreciation and Depletion 213,872368,673477,121528,118533,360
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit (1.06M)529,217264,609264,609-
Deferred Taxes (1.06M)529,217264,609264,609-
Investment Tax Credit -----
Other Funds 15.26M16.65M19.85M23.68M30.4M
Funds from Operations (83.36M)(137.58M)(127.13M)(202.53M)(253.19M)
Extraordinaries -----
Changes in Working Capital 2.86M19.41M(1.74M)(27.47M)(6.18M)
Receivables 94,339--(10.76M)(9.39M)
Accounts Payable 2.42M7.79M(6.54M)(1.92M)3.19M
Other Assets/Liabilities (879,200)(3.03M)1.47M(7.92M)(11.21M)
Net Operating Cash Flow (80.49M)(118.17M)(128.87M)(230M)(259.37M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (723,429)(391,268)(700,395)(266,724)(325,738)
Capital Expenditures (Fixed Assets) (723,429)(391,268)(700,395)(266,724)(325,738)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments (91.99M)135.03M178.14M(480.03M)280.67M
Purchase of Investments (520.93M)(271.16M)(80.72M)(755.63M)(224.57M)
Sale/Maturity of Investments 428.93M406.19M258.86M275.6M505.24M
Other Uses -----
Other Sources -----
Net Investing Cash Flow (92.72M)134.64M177.44M(480.3M)280.34M

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 162.36M685,1883.24M664.18M11.52M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 162.36M685,1883.24M664.18M11.52M
Proceeds from Stock Options 162.07M--652.71M-
Other Proceeds from Sale of Stock 285,160685,1883.24M11.46M11.52M
Issuance/Reduction of Debt, Net --889,468(73,160)(175,110)
Change in Current Debt --889,468(73,160)(175,110)
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 162.36M685,1884.13M664.1M11.34M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (10.85M)17.16M52.69M(46.19M)32.32M
Free Cash Flow (81.22M)(118.56M)(129.57M)(230.27M)(259.69M)
Link to MarketWatch's Slice.